Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 231-836-6 | CAS number: 7758-19-2
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Acute Toxicity: oral
Administrative data
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 984
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 401 (Acute Oral Toxicity)
- Deviations:
- no
- GLP compliance:
- yes
- Test type:
- standard acute method
- Limit test:
- no
Test material
- Reference substance name:
- Sodium chlorite
- EC Number:
- 231-836-6
- EC Name:
- Sodium chlorite
- Cas Number:
- 7758-19-2
- Molecular formula:
- ClHO2.Na
- IUPAC Name:
- sodium chlorite
- Test material form:
- liquid
- Remarks:
- Aqueous solution
- Details on test material:
- Test material: Sodium chlorite (25 % aqueous solution)
Lot/Batch number: 403 D
Description: Pale yellow liquid
Purity: 25.3 % aqueous solution
Constituent 1
Test animals
- Species:
- rat
- Strain:
- Sprague-Dawley
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- Source:Charles River, France
Weight (average) at study initiation: male 150 g; female 133 g
Administration / exposure
- Route of administration:
- oral: gavage
- Vehicle:
- water
- Details on oral exposure:
- Postexposure period: 14 days
- Doses:
- 150, 200, 250, 400, 450 and 500 mg/kg
Concentration in vehicle:15, 20, 25, 40, 45 and 50 mg/ml
Total volume applied:10 ml/kg - No. of animals per sex per dose:
- 5 animals/sex/group
- Control animals:
- no
- Details on study design:
- Clinical signs, mortality, body weight and pathology were assessed in the study.
Results and discussion
Effect levelsopen allclose all
- Key result
- Sex:
- male/female
- Dose descriptor:
- LD50
- Effect level:
- 284 mg/kg bw
- Based on:
- test mat.
- 95% CL:
- 204 - 347
- Remarks on result:
- other: LD50 value for sodium chlorite
- Key result
- Sex:
- male/female
- Dose descriptor:
- LD50
- Effect level:
- 212 mg/kg bw
- Based on:
- act. ingr.
- Remarks on result:
- other: LD50 value for chlorite
- Mortality:
- No mortality was observed at doses of 150 and 200 mg/kg. At doses of 250, 400, 450 and 500 mg/kg, mortality appears from the first day, one hour after treatment, and occurs until day 4 (see table A6_1_1(2)-1).
- Clinical signs:
- other: Effects are observed 15 to 30 minutes after administration of the product. Hypokinesia, cyanosis and prostration were noted. Animals were found in a position of lateral or ventral decubitus.
- Gross pathology:
- No macroscopic lesions attributable to the treatment were observed for doses of 150 and 200 mg/kg. Brown colouration of the organs of the abdominal and thoracic cavity was observed for animals treated at doses of 250, 400, 450 and 500 mg/kg. Each organ presenting macroscopic abnormalities was removed and conserved in the appropriate fixing agent.
Any other information on results incl. tables
Table A6_1_1(2)-1. Table for Acute Toxicity |
|||||||
Dose (mg/kg) |
% mortality |
Time of death (range) |
Observations |
||||
male |
female |
male + female |
male |
female |
|||
150 |
0 |
0 |
0 |
- |
- |
||
200 |
0 |
0 |
0 |
- |
- |
||
250 |
60 |
100 |
80 |
day 1 |
day 0 (1h) |
||
400 |
60 |
60 |
60 |
day 0 (3h) |
day 0 (3h) |
||
450 |
60 |
100 |
80 |
day 0 (3h) |
day 0 (3h) |
||
500 |
100 |
80 |
90 |
day 0 (3h) |
day 0 (1h) |
||
LD50 value |
238 mg/kg (95% C.L. = 203.70 – 346.50 mg/kg) |
|
|||||
Applicant's summary and conclusion
- Interpretation of results:
- Category 3 based on GHS criteria
- Conclusions:
- The LD50 of Sodium chlorite (pure active) administered orally is 284 mg/kg, with 95% confidence limits of 204 and 347 mg/kg (equivalent to 212 mg/kg as chlorite). At doses of 150 and 200 mg/kg the treatment does not cause any effects. At higher doses, the effects appear at least 30 minutes after treatment and include hypokinesia, cyanosis, prostration and piloerection. Certain animals are in a position of lateral or ventral decubitus. There are no dose-related body weight changes at 150 mg/kg, whereas at higher doses there is body weight loss in some animals between days 0 and 4, but this is regained from days 7 to 14. A macroscopic examination of the organs of animals treated at 150 and 200 mg/kg did not reveal any anomalies. At higher doses macroscopic anomalies are observed in organs of the abdominal and thoracic cavity (brown colouration).
- Executive summary:
The aim of the study was to determine the oral acute toxicity due to the test material.
The test procedure was performed according to OECD Guideline 401 (Acute Oral Toxicity) under GLP conditions.
Concentrations: 150, 200, 250, 400, 450 and 500 mg/kg.
The results were as follows:
The LD50 of Sodium chlorite (pure active) administered orally is 284 mg/kg, with 95% confidence limits of 204 and 347 mg/kg (equivalent to 212 mg/kg as chlorite).
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.

EU Privacy Disclaimer
This website uses cookies to ensure you get the best experience on our websites.